Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells.
Clinical trial NCT00289341 · COMPLETED
Trial details
- NCT number
- NCT00289341
- Sponsor
- Rockefeller University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-03-01
- Primary completion
- 2008-11-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.